Grünenthal is a global leader in pain management and related diseases.
As a science-based, privately-owned pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on moving towards our vision of a world free of pain.
Annual Report 2023/24
4,400 Grünenthal employees worldwide join forces every day to drive progress towards our vision of a World Free of Pain. Together, we achieved record revenues in 2023. And our scientists made important progress with developing innovative medicines for pain patients.
Our most recent report shares information about our company’s strategy, highlight projects and financial performance.
Responsibility Report 2023
Pioneering thinkers
The power of partnerships
Careers
Ready to create a brighter future for our patients? With us, let your passion and ideas flow and drive innovation to improve our patients’ lives.
Join forces.
Make an impact.
Innovate for a world free of pain.
Work with Grünenthal